BIOMAT Database Logo BIOMAT Database Logo

Development of an optimum dosage regimen for pentobarbital in patients with severe head injury. 1987

K Nishihara, and Y Kohda, and H Tsutsumi, and M Sasaki, and T Aruga, and H Toyooka, and K Mii

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010424 Pentobarbital A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236) Mebubarbital,Mebumal,Diabutal,Etaminal,Ethaminal,Nembutal,Pentobarbital Sodium,Pentobarbital, Monosodium Salt,Pentobarbitone,Sagatal,Monosodium Salt Pentobarbital
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006259 Craniocerebral Trauma Traumatic injuries involving the cranium and intracranial structures (i.e., BRAIN; CRANIAL NERVES; MENINGES; and other structures). Injuries may be classified by whether or not the skull is penetrated (i.e., penetrating vs. nonpenetrating) or whether there is an associated hemorrhage. Frontal Region Trauma,Head Injuries,Head Trauma,Occipital Region Trauma,Parietal Region Trauma,Temporal Region Trauma,Craniocerebral Injuries,Crushing Skull Injury,Forehead Trauma,Head Injuries, Multiple,Head Injury, Minor,Head Injury, Open,Head Injury, Superficial,Injuries, Craniocerebral,Injuries, Head,Multiple Head Injuries,Occipital Trauma,Open Head Injury,Superficial Head Injury,Trauma, Head,Craniocerebral Injury,Craniocerebral Traumas,Crushing Skull Injuries,Forehead Traumas,Frontal Region Traumas,Head Injuries, Minor,Head Injuries, Open,Head Injuries, Superficial,Head Injury,Head Injury, Multiple,Head Traumas,Injuries, Minor Head,Injuries, Multiple Head,Injuries, Open Head,Injuries, Superficial Head,Injury, Craniocerebral,Injury, Head,Injury, Minor Head,Injury, Multiple Head,Injury, Open Head,Injury, Superficial Head,Minor Head Injuries,Minor Head Injury,Multiple Head Injury,Occipital Region Traumas,Occipital Traumas,Open Head Injuries,Parietal Region Traumas,Region Trauma, Frontal,Region Trauma, Occipital,Region Trauma, Parietal,Region Traumas, Frontal,Region Traumas, Occipital,Region Traumas, Parietal,Skull Injuries, Crushing,Skull Injury, Crushing,Superficial Head Injuries,Temporal Region Traumas,Trauma, Craniocerebral,Trauma, Forehead,Trauma, Frontal Region,Trauma, Occipital,Trauma, Occipital Region,Trauma, Parietal Region,Trauma, Temporal Region,Traumas, Craniocerebral,Traumas, Forehead,Traumas, Frontal Region,Traumas, Head,Traumas, Occipital,Traumas, Occipital Region,Traumas, Parietal Region,Traumas, Temporal Region
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

K Nishihara, and Y Kohda, and H Tsutsumi, and M Sasaki, and T Aruga, and H Toyooka, and K Mii
Pentobarbital pharmacokinetics in patients with severe head injury.
May 1987, Drug intelligence & clinical pharmacy,
K Nishihara, and Y Kohda, and H Tsutsumi, and M Sasaki, and T Aruga, and H Toyooka, and K Mii
Optimum dosage regimen for iron sucrose.
July 2007, Kidney international,
K Nishihara, and Y Kohda, and H Tsutsumi, and M Sasaki, and T Aruga, and H Toyooka, and K Mii
Optimum dosage regimen of palivizumab?
June 2002, Therapeutic drug monitoring,
K Nishihara, and Y Kohda, and H Tsutsumi, and M Sasaki, and T Aruga, and H Toyooka, and K Mii
Development of guidelines for severe head injury.
April 1997, Bulletin of the American College of Surgeons,
K Nishihara, and Y Kohda, and H Tsutsumi, and M Sasaki, and T Aruga, and H Toyooka, and K Mii
Optimum serum glucose levels for patients with severe traumatic brain injury.
May 2009, F1000 medicine reports,
K Nishihara, and Y Kohda, and H Tsutsumi, and M Sasaki, and T Aruga, and H Toyooka, and K Mii
Prognosis in patients with severe head injury.
January 1979, Acta neurochirurgica. Supplementum,
K Nishihara, and Y Kohda, and H Tsutsumi, and M Sasaki, and T Aruga, and H Toyooka, and K Mii
Aggressive out-of-hospital treatment regimen for severe closed head injury in patients undergoing air medical transport.
January 1998, Air medical journal,
K Nishihara, and Y Kohda, and H Tsutsumi, and M Sasaki, and T Aruga, and H Toyooka, and K Mii
Prognosis of patients with severe head injury.
April 1979, Neurosurgery,
K Nishihara, and Y Kohda, and H Tsutsumi, and M Sasaki, and T Aruga, and H Toyooka, and K Mii
Moderate hypothermia therapy for patients with severe head injury.
August 2001, Chinese journal of traumatology = Zhonghua chuang shang za zhi,
K Nishihara, and Y Kohda, and H Tsutsumi, and M Sasaki, and T Aruga, and H Toyooka, and K Mii
[Optimum dosage of pergolide in patients with Parkinson's disease].
April 2005, Rinsho shinkeigaku = Clinical neurology,
Copied contents to your clipboard!